Translation Of “New Biology” Into Clinical Use Identified By DeVita As NCI’s Major Challenge
In Brief: James Carr Replaces Murphy As Interim Director of Organ Systems Coordinating Center In N.Y.
CDC Warns Burton Patients Of Risk Of HTLV-3 Infection
Smokeless Tobacco Consensus Conference Slates in Health Risks
Cancer Letter Goes On Vacation
NCI Advisory Group, Other Cancer Meetings
Trending Stories
- An opportunity for Trump: Position U.S. cancer science to lead the world
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs
To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges - Former Maryland Governor Larry Hogan to receive Public Service Leadership Award from National Coalition for Cancer Survivorship
- Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”